An Interventional Approach to Pancreatic Cancer | Steve's Story | Weill Cornell Medicine

Being diagnosed with advanced metastatic pancreatic cancer was a grim experience for Steve Price. But thanks to his doctors at Weill Cornell Medicine and NewYork-Presbyterian, state-of-the-art interventional radiology allowed him to receive chemotherapy immediately after biopsy, shrinking his tumors dramatically. Then, a precision medicine clinical trial revealed that Price had a mutation in the BRCA1 gene, normally associated with breast cancer. By examining his unique genetic profile, Price’s medical team was able to determine that a new therapy targeting the mutation could give him his life back.

Interested in learning more about our team of doctors, their patients and how our research is changing lives? Like and subscribe to make sure you never miss out on any of our upcoming videos.

Steve’s Care Team
Dr. Allyson Ocean, please visit http://bit.ly/2E5hKWk
Dr. Olivier Elemento, please visit http://bit.ly/2QCsYrZ

Sandra and Edward Meyer Cancer Center please visit http://bit.ly/2E2BdqN
The Englander Institute for Precision Medicine please visit http://bit.ly/2QHabvG

Dr. Kyungmouk Steve Lee, please visit http://bit.ly/2E2na4y
Dr. Robert Min, please visit http://bit.ly/2E5BTfa
Interventional Radiology please visit http://bit.ly/2E5BRny

To learn more about Weill Cornell Medicine patient care please visit here. https://weillcornell.org/ To learn about education and research at Weill Cornell Medicine visit here. http://weill.cornell.edu/

Keep up with our social posts on
Facebook https://www.facebook.com/WeillCornellMedicine
Twitter https://twitter.com/weillcornell
Instagram https://www.instagram.com/weillcornell
LinkedIn https://www.linkedin.com/company/3522/